NCT02958995View on ClinicalTrials.gov

Epidemiologic Study Of Diabetes And Cancer Risk

CompletedOBSERVATIONAL
Enrollment

2,738,161

Participants

Timeline

Start Date

January 1, 1997

Primary Completion Date

May 29, 2015

Study Completion Date

May 29, 2015

Conditions
Diabetes Mellitus, Type 2, Cancer
Interventions
OTHER

No Intervention

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT02958995 - Epidemiologic Study Of Diabetes And Cancer Risk | Biotech Hunter | Biotech Hunter